GlassScriptPhysician profile
Casey Michaelle White
NPI 1740906437
$1,648.63
in general payments reported to CMS, 2019-2025
8 companies · $881 in 2025
The $881 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $210 · 2024: $557 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,648.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $473.03 | 2023-2025 | Epclusa |
| Intercept Pharmaceuticals, INC. | $458.30 | 2023-2025 | Ocaliva |
| Madrigal Pharmaceuticals | $288.46 | 2024-2025 | Rezdiffra, Resmetirom |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.21 | 2023-2025 | Xifaxan |
| Ipsen Biopharmaceuticals, INC | $153.29 | 2024-2025 | Iqirvo |
| Abbvie INC. | $44.65 | 2024 | |
| Eton Pharmaceuticals, INC. | $23.94 | 2025 | Khindivi, Increlex, Alkindi |
| Takeda Pharmaceuticals U.S.A., INC. | $20.75 | 2024 | Vpriv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.